Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 2 10Phase EARLY_PHASE1 4Phase 1 2Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 6Recruiting 5Terminated 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 118Other hematologic neoplasm 106Gastrointestinal 79Thoracic 59Breast 59Genitourinary 54CNS 54Other solid neoplasm 43Gynecologic 43Sarcoma 36Tumor-Agnostic 35Dermatologic 30Head & Neck 27Plasma cell 26Myeloid 22Endocrine 6Other neoplasm 4NET 3Other 2

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

lorcaserin 1Radiotherapy, Intensity-Modulated 1Cisplatin 1CBLB502 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Withdrawn × Other × Clear all
NCT04205071 2021-01-19

Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase 1 Withdrawn
BreastOther

Anatomic Stage I Breast Cancer AJCC v8

NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡